Kainate receptors mediate regulated exocytosis of secretory phospholipase A 2 in SH-SY5Y neuroblastoma cells

NeuroSignals

Volumn 20, Issue 2, 2012, Pages 72-85

  Than, Aung ^a   Tan, Yan ^b   Ong, Wei Yi ^b   Farooqui, Akhlaq A ^c   Chen, Peng ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Exocytosis; GluR5; Group IIA secretory phospholipase A 2; Kainate receptors; Neurotransmission; Nociception; Pain; Protein kinase C; Secretory phospholipase A 2; Synaptic plasticity

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM ION; GLUTAMATE RECEPTOR AGONIST; KAINIC ACID; KAINIC ACID RECEPTOR; PROTEIN KINASE C; SECRETORY PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEGENERATIVE DISEASE; EXOCYTOSIS; HUMAN; HUMAN CELL; NERVE CELL PLASTICITY; NEUROBLASTOMA CELL; NONHUMAN; PAIN; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; EXCITATORY AMINO ACID AGONISTS; EXOCYTOSIS; GROUP II PHOSPHOLIPASES A2; HUMANS; KAINIC ACID; NEURONS; RATS; RECEPTORS, KAINIC ACID; SIGNAL TRANSDUCTION;

EID: 84859002064     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000330414     Document Type: Article

References (91)

1. Hanasaki K, Arita H: Purification and characterization of a high-affinity binding protein for pancreatic-type phospholipase A 2 . Biochim Biophys Acta 1992; 1127: 233-241.
2. Dennis EA: The growing phospholipase A 2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997; 22: 1-2. (Pubitemid 27056087)
3. Tischfield JA: A reassessment of the low molecular weight phospholipase A 2 gene family in mammals. J Biol Chem 1997; 272: 17247-17250. (Pubitemid 27311145)
4. Murakami M, Kudo I: Phospholipase A 2 . J Biochem 2002; 131: 285-292.
5. Wang G, Zhou D, Wang C, Gao Y, Zhou Q, Qian G, DeCoster MA: Hypoxic preconditioning suppresses group III secreted phospholipase A 2 -induced apoptosis via JAK2- STAT3 activation in cortical neurons. J Neurochem 2010; 114: 1039-1048.
6. Ma MT, Nevalainen TJ, Yeo JF, Ong WY: Expression profile of multiple secretory phospholipase A 2 isoforms in the rat CNS: enriched expression of sPLA 2 -IIA in brainstem and spinal cord. J Chem Neuroanat 2010; 39: 242-247.
7. Kolko M, Christoffersen NR, Barreiro SG, Miller ML, Pizza AJ, Bazan NG: Characterization and location of secretory phospholipase A 2 groups IIE, V, and X in the rat brain. J Neurosci Res 2006; 83: 874-882.
8. Thwin MM, Ong WY, Fong CW, Sato K, Kodama K, Farooqui AA, Gopalakrishnakone P: Secretory phospholipase A 2 activity in the normal and kainate injected rat brain, and inhibition by a peptide derived from python serum. Exp Brain Res 2003; 150: 427-433. (Pubitemid 36791655)
9. Massicotte G, Baudry M: Triggers and substrates of hippocampal synaptic plasticity. Neurosci Biobehav Rev 1991; 15: 415-423.
10. Fujita S, Ikegaya Y, Nishikawa M, Nishiyama N, Matsuki N: Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A 2 inhibitor in rat hippocampal slices. Br J Pharmacol 2001; 132: 1417-1422. (Pubitemid 32281029)
11. Bliss TV, Collingridge GL: A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-39. (Pubitemid 23020772)
12. Dumuis A, Sebben M, Haynes L, Pin JP, Bockaert J: NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 1988; 336: 68-70. (Pubitemid 18262135)
13. Bliss TV, Errington ML, Lynch MA, Williams JH: Presynaptic mechanisms in hippocampal long-term potentiation. Cold Spring Harb Symp Quant Biol 1990; 55: 119-129.
14. Williams JH, Errington ML, Lynch MA, Bliss TV: Arachidonic acid induces a longterm activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 1989; 341: 739-742. (Pubitemid 19260887)
15. Ma MT, Yeo JF, Farooqui AA, Zhang J, Chen P, Ong WY: Differential effects of lysophospholipids on exocytosis in rat PC12 cells. J Neural Transm 2010; 117: 301-308.
16. Nomura T, Nishizaki T, Enomoto T, Itoh H: A long-lasting facilitation of hippocampal neurotransmission via a phospholipase A 2 signaling pathway. Life Sci 2001; 68: 2885-2891. (Pubitemid 32448894)
17. Massicotte G, Oliver MW, Lynch G, Baudry M: Effect of bromophenacyl bromide, a phospholipase A 2 inhibitor, on the induction and maintenance of LTP in hippocampal slices. Brain Res 1990; 537: 49-53.
18. Okada D, Yamagishi S, Sugiyama H: Differential effects of phospholipase inhibitors in long-term potentiation in the rat hippocampal mossy fiber synapses and Schaffer/commissural synapses. Neurosci Lett 1989; 100: 141-146. (Pubitemid 19128164)
19. Molloy GY, Rattray M, Williams RJ: Genes encoding multiple forms of phospholipase A 2 are expressed in rat brain. Neurosci Lett 1998; 258: 139-142. (Pubitemid 29023567)
20. Svensson CI, Lucas KK, Hua XY, Powell HC, Dennis EA, Yaksh TL: Spinal phospholipase A 2 in inflammatory hyperalgesia: role of the small, secretory phospholipase A 2 . Neuroscience 2005; 133: 543-553. (Pubitemid 40726220)
21. Yeo JF, Ong WY, Ling SF, Farooqui AA: Intracerebroventricular injection of phospholipases A 2 inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 2004; 112: 148-155. (Pubitemid 39371030)
22. Lin TN, Wang Q, Simonyi A, Chen JJ, Cheung WM, He YY, Xu J, Sun AY, Hsu CY, Sun GY: Induction of secretory phospholipase A 2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J Neurochem 2004; 90: 637-645. (Pubitemid 38989394)
23. Lauritzen I, Heurteaux C, Lazdunski M: Expression of group II phospholipase A 2 in rat brain after severe forebrain ischemia and in endotoxic shock. Brain Res 1994; 651: 353-356. (Pubitemid 24222889)
24. Titsworth WL, Cheng X, Ke Y, Deng L, Burckardt KA, Pendleton C, Liu NK, Shao H, Cao QL, Xu XM: Differential expression of sPL A 2 following spinal cord injury and a functional role for sPLA 2 -IIA in mediating oligodendrocyte death. Glia 2009; 57: 1521-1537.
25. Moses GS, Jensen MD, Lue LF, Walker DG, Sun AY, Simonyi A, Sun GY: Secretory PLA 2 - IIa: A new inflammatory factor for Alzheimer's disease. J Neuroinflammation 2006; 3: 28.
26. Adibhatla RM, Hatcher JF: Secretory phospholipase A 2 IIA is up-regulated by TNF-alpha and IL-1/ after transient focal cerebral ischemia in rat. Brain Res 2007; 1134: 199-205. (Pubitemid 46135540)
27. Thomas G, Bertrand F, Saunier B: The differential regulation of group IIA and group V low molecular weight phospholipases A 2 in cultured rat astrocytes. J Biol Chem 2000; 275: 10876-10886. (Pubitemid 30212721)
28. Yagami T, Ueda K, Asakura K, Hata S, Kuroda T, Sakaeda T, Takasu N, Tanaka K, Gemba T, Hori Y: Human group IIA secretory phospholipase A 2 induces neuronal cell death via apoptosis. Mol Pharmacol 2002; 61: 114-126. (Pubitemid 34049518)
29. Kolko M, de Turco EB, Diemer NH, Bazan NG: Secretory phospholipase A 2 -mediated neuronal cell death involves glutamate ionotropic receptors. Neuroreport 2002; 13: 1963-1966. (Pubitemid 35402120)
30. Yagami T, Ueda K, Asakura K, Nakazato H, Hata S, Kuroda T, Sakaeda T, Sakaguchi G, Itoh N, Hashimoto Y, Hori Y: Human group IIA secretory phospholipase A 2 potentiates Ca 2+ influx through L-type voltage-sensitive Ca 2+ channels in cultured rat cortical neurons. J Neurochem 2003; 85: 749-758. (Pubitemid 36531938)
31. Madden DR: The structure and function of glutamate receptor ion channels. Nat Rev Neurosci 2002; 3: 91-101. (Pubitemid 135706578)
32. Bettler B, Mulle C: Review: neurotransmitter receptors. II. AMPA and kainate receptors. Neuropharmacology 1995; 34: 123-139.
33. Huettner JE: Kainate receptors and synaptic transmission. Prog Neurobiol 2003; 70: 387-407. (Pubitemid 37159280)
34. Keinanen K, Wisden W, Sommer B, Werner P, Herb A, Verdoorn TA, Sakmann B, Seeburg PH: A family of AMPA-selective glutamate receptors. Science 1990; 249: 556-560.
35. Iremonger KJ, Benediktsson AM, Bains JS: Glutamatergic synaptic transmission in neuroendocrine cells: basic principles and mechanisms of plasticity. Front Neuroendocrinol 2010; 31: 296-306.
36. Lerma J: Roles and rules of kainate receptors in synaptic transmission. Nat Rev Neurosci 2003; 4: 481-495. (Pubitemid 37280169)
37. Poli A, Contestabile A, Migani P, Rossi L, Rondelli C, Virgili M, Bissoli R, Barnabei O: Kainic acid differentially affects the synaptosomal release of endogenous and exogenous amino acidic neurotransmitters. J Neurochem 1985; 45: 1677-1686. (Pubitemid 16204293)
38. Caruso C, Durand D, Watanobe H, Lasaga M: NMDA and group I metabotropic glutamate receptors activation modulates substance P release from the arcuate nucleus and median eminence. Neurosci Lett 2006; 393: 60-64. (Pubitemid 41739654)
39. Rodriguez-Moreno A, Sihra TS: Kainate receptors with a metabotropic modus operandi. Trends Neurosci 2007; 30: 630-637. (Pubitemid 350101852)
40. Wei S, Ong WY, Thwin MM, Fong CW, Farooqui AA, Gopalakrishnakone P, Hong W: Group IIA secretory phospholipase A 2 stimulates exocytosis and neurotransmitter release in pheochromocytoma-12 cells and cultured rat hippocampal neurons. Neuroscience 2003; 121: 891-898. (Pubitemid 37324588)
41. Matsuzawa A, Murakami M, Atsumi G, Imai K, Prados P, Inoue K, Kudo I: Release of secretory phospholipase A 2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem J 1996; 318: 701-709. (Pubitemid 26305977)
42. Suzuki N, Ishizaki J, Yokota Y, Higashino K, Ono T, Ikeda M, Fujii N, Kawamoto K, Hanasaki K: Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A 2 s. J Biol Chem 2000; 275: 5785-5793. (Pubitemid 30115223)
43. Nyman KM, Ojala P, Laine VJ, Nevalainen TJ: Distribution of group II phospholipase A 2 protein and mRNA in rat tissues. J Histochem Cytochem 2000; 48: 1469-1478.
44. Holz RW, Axelrod D: Secretory granule behaviour adjacent to the plasma membrane before and during exocytosis: total internal reflection fluorescence microscopy studies. Acta Physiol (Oxf) 2008; 192: 303-307. (Pubitemid 351161002)
45. Ye F, Than A, Zhao Y, Goh KH, Chen P: Vesicular storage, vesicle trafficking, and secretion of leptin and resistin: the similarities, differences, and interplays. J Endocrinol 2010; 206: 27-36.
46. Zhang J, Xue R, Ong WY, Chen P: Roles of cholesterol in vesicle fusion and motion. Biophys J 2009; 97: 1371-1380.
47. Than A, Ye F, Xue R, Ong JW, Poh CL, Chen P: The crosstalks between adipokines and catecholamines. Mol Cell Endocrinol 2011; 332: 261-270.
48. Marqueze B, Boudier JA, Mizuta M, Inagaki N, Seino S, Seagar M: Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat. J Neurosci 1995; 15: 4906-4917.
49. Walch-Solimena C, Takei K, Marek KL, Midyett K, Sudhof TC, De Camilli P, Jahn R: Synaptotagmin: a membrane constituent of neuropeptide-containing large dense-core vesicles. J Neurosci 1993; 13: 3895-3903. (Pubitemid 23264373)
50. More JC, Nistico R, Dolman NP, Clarke VR, Alt AJ, Ogden AM, Buelens FP, Troop HM, Kelland EE, Pilato F, Bleakman D, Bortolotto ZA, Collingridge GL, Jane DE: Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist. Neuropharmacology 2004; 47: 46-64. (Pubitemid 38686310)
51. Verdoorn TA, Johansen TH, Drejer J, Nielsen EO: Selective block of recombinant GluR6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur J Pharmacol 1994; 269: 43-49.
52. Foster DJ, Vitvitsky VM, Banerjee R, Heacock AM, Fisher SK: Muscarinic receptor regulation of osmosensitive taurine transport in human SH-SY5Y neuroblastoma cells. J Neurochem 2009; 108: 437-449.
53. Morgan A, Burgoyne RD, Barclay JW, Craig TJ, Prescott GR, Ciufo LF, Evans GJ, Graham ME: Regulation of exocytosis by protein kinase C. Biochem Soc Trans 2005; 33: 1341-1344. (Pubitemid 41779683)
54. Wilkinson SE, Parker PJ, Nixon JS: Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 1993; 294: 335-337. (Pubitemid 23268828)
55. Xue R, Zhao Y, Chen P: Involvement of PKC in PMA-induced facilitation of exocytosis and vesicle fusion in PC12 cells. Biochem Biophys Res Commun 2009; 380: 371-376.
56. Hatori K, Nagai A, Heisel R, Ryu JK, Kim SU: Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 2002; 69: 418-426. (Pubitemid 34809490)
57. Murphy NP, McCormack JG, Ball SG, Vaughan PF: The effect of protein kinase C activation on muscarinic-M3- and K + - evoked release of [ 3 H]noradrenaline and increases in intracellular Ca 2+ in human neuroblastoma SH-SY5Y cells. Biochem J 1992; 282: 645-650.
58. Leondaritis G, Petrikkos L, Mangoura D: Regulation of the Ras-GTPase activating protein neurofibromin by C-tail phosphorylation: implications for protein kinase C/ Ras/extracellular signal-regulated kinase 1/2 pathway signaling and neuronal differentiation. J Neurochem 2009; 109: 573-583.
59. Gatta V, Drago D, Fincati K, Valenti MT, Dalle Carbonare L, Sensi SL, Zatta P: Microarray analysis on human neuroblastoma cells exposed to aluminum, (1-42)-amyloid or the (1-42)-amyloid aluminum complex. PLoS One 2011; 6:e15965.
60. Agholme L, Lindstrom T, Kagedal K, Marcusson J, Hallbeck M: An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimers Dis 2010; 20: 1069-1082.
61. Pickel VM, Joh TH, Reis DJ, Leeman SE, Miller RJ: Electron microscopic localization of substance P and enkephalin in axon terminals related to dendrites of catecholaminergic neurons. Brain Res 1979; 160: 387-400. (Pubitemid 9060951)
62. Jarvi R, Helen P, Pelto-Huikko M, Hervonen A: Neuropeptide Y (NPY)-like immunoreactivity in rat sympathetic neurons and small granule-containing cells. Neurosci Lett 1986; 67: 223-227. (Pubitemid 16034552)
63. Schwab Y, Mouton J, Chasserot-Golaz S, Marty I, Maulet Y, Jover E: Calcium-dependent translocation of synaptotagmin to the plasma membrane in the dendrites of developing neurones. Brain Res Mol Brain Res 2001; 96: 1-13. (Pubitemid 33145358)
64. Maher BJ, Mackinnon RL 2nd, Bai J, Chapman ER, Kelly PT: Activation of postsynaptic Ca 2+ stores modulates glutamate receptor cycling in hippocampal neurons. J Neurophysiol 2005; 93: 178-188. (Pubitemid 40626833)
65. Naarala J, Nykvist P, Tuomala M, Savolainen K: Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells. FEBS Lett 1993; 330: 222-226. (Pubitemid 23265136)
66. Nair VD, Niznik HB, Mishra RK: Interaction of NMDA and dopamine D2L receptors in human neuroblastoma SH-SY5Y cells. J Neurochem 1996; 66: 2390-2393.
67. Cannarsa R, Landuzzi D, Cavina C, Candeletti S, Romualdi P: Kainic acid down-regulates NOP receptor density and gene expression in human neuroblastoma SH-SY5Y cells. J Mol Neurosci 2008; 35: 171-177.
68. Kim SJ, Han Y: Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (AKT). J Neural Transm 2005; 112: 179-191. (Pubitemid 40179112)
69. Tetich M, Kutner A, Leskiewicz M, Budziszewska B, Lason W: Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line. J Steroid Biochem Mol Biol 2004; 89-90: 365-370. (Pubitemid 38844312)
70. Singh J, Kaur G: Neuroprotection mediated by subtoxic dose of NMDA in SH-SY5Y neuroblastoma cultures: activity-dependent regulation of PSA-NCAM expression. Brain Res Mol Brain Res 2005; 137: 223-234. (Pubitemid 40798905)
71. Gao M, Zhang WC, Liu QS, Hu JJ, Liu GT, Du GH: Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio. Eur J Pharmacol 2008; 591: 73-79.
72. Sun ZW, Zhang L, Zhu SJ, Chen WC, Mei B: Excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damage. Neurosci Bull 2010; 26: 8-16.
73. Paternain AV, Herrera MT, Nieto MA, Lerma J: GluR5 and GluR6 kainate receptor subunits coexist in hippocampal neurons and coassemble to form functional receptors. J Neurosci 2000; 20: 196-205. (Pubitemid 30220507)
74. Sommer B, Burnashev N, Verdoorn TA, Keinanen K, Sakmann B, Seeburg PH: A glutamate receptor channel with high affinity for domoate and kainate. EMBO J 1992; 11: 1651-1656.
75. Vignes M, Collingridge GL: The synaptic activation of kainate receptors. Nature 1997; 388: 179-182. (Pubitemid 27297454)
76. Jakobsen B, Tasker A, Zimmer J: Domoic acid neurotoxicity in hippocampal slice cultures. Amino Acids 2002; 23: 37-44.
77. Wondolowski J, Frerking M: Subunit-dependent postsynaptic expression of kainate receptors on hippocampal interneurons in area CA1. J Neurosci 2009; 29: 563-574.
78. Burgoyne RD, Morgan A: Secretory granule exocytosis. Physiol Rev 2003; 83: 581-632. (Pubitemid 36378679)
79. Misonou H, Ohara-Imaizumi M, Murakami T, Kawasaki M, Ikeda K, Wakai T, Kumakura K: Protein kinase C controls the priming step of regulated exocytosis in adrenal chromaffin cells. Cell Mol Neurobiol 1998; 18: 379-390. (Pubitemid 28249344)
80. Bendotti C, Baldessari S, Samanin R, De Biasi S: Ultrastructural immunolocalization of GAP-43 in the sprouted mossy fibres of kainic acid lesioned rats. Neuroreport 1994; 5: 2645-2648.
81. McNamara RK, Routtenberg A: NMDA receptor blockade prevents kainate induction of protein F1/GAP-43 mRNA in hippocampal granule cells and subsequent mossy fiber sprouting in the rat. Brain Res Mol Brain Res 1995; 33: 22-28.
82. Melyan Z, Wheal HV, Lancaster B: Metabotropic- mediated kainate receptor regulation of IsAHP and excitability in pyramidal cells. Neuron 2002; 34: 107-114. (Pubitemid 34270702)
83. Cho K, Francis JC, Hirbec H, Dev K, Brown MW, Henley JM, Bashir ZI: Regulation of kainate receptors by protein kinase C and metabotropic glutamate receptors. J Physiol 2003; 548: 723-730. (Pubitemid 36592768)
84. Massicotte G, Vanderklish P, Lynch G, Baudry M: Modulation of DL-amino-3-hydroxy- 5-methyl-4-isoxazolepropionic acid/ quisqualate receptors by phospholipase A 2 : a necessary step in long-term potentiation? Proc Natl Acad Sci USA 1991; 88: 1893-1897. (Pubitemid 21916333)
85. Wolf MJ, Izumi Y, Zorumski CF, Gross RW: Long-term potentiation requires activation of calcium-independent phospholipase A 2 . FEBS Lett 1995; 377: 358-362. (Pubitemid 26027153)
86. Li P, Wilding TJ, Kim SJ, Calejesan AA, Huettner JE, Zhuo M: Kainate-receptor-mediated sensory synaptic transmission in mammalian spinal cord. Nature 1999; 397: 161-164.
87. Hegarty DM, Mitchell JL, Swanson KC, Aicher SA: Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn. Brain Res 2007; 1184: 149-159. (Pubitemid 350160589)
88. Sutton JL, Maccecchini ML, Kajander KC: The kainate receptor antagonist 2 S ,4 R -4- methylglutamate attenuates mechanical allodynia and thermal hyperalgesia in a rat model of nerve injury. Neuroscience 1999; 91: 283-292. (Pubitemid 29170466)
89. Ta LE, Dionne RA, Fricton JR, Hodges JS, Kajander KC: Sym-2081 a kainate receptor antagonist reduces allodynia and hyperalgesia in a freeze injury model of neuropathic pain. Brain Res 2000; 858: 106-120. (Pubitemid 30105788)
90. Simmons RM, Li DL, Hoo KH, Deverill M, Ornstein PL, Iyengar S: Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 1998; 37: 25-36. (Pubitemid 28300135)
91. Ko S, Zhao MG, Toyoda H, Qiu CS, Zhuo M: Altered behavioral responses to noxious stimuli and fear in glutamate receptor 5 (GluR5)- or GluR6-deficient mice. J Neurosci 2005; 25: 977-984. (Pubitemid 40171014)